Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Inventory (2016 - 2025)

Icu Medical (ICUI) has disclosed Change in Inventory for 17 consecutive years, with -$10.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 34.37% year-over-year to -$10.0 million, compared with a TTM value of $26.3 million through Dec 2025, up 255.99%, and an annual FY2025 reading of $26.3 million, up 255.99% over the prior year.
  • Change in Inventory was -$10.0 million for Q4 2025 at Icu Medical, down from $7.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $63.9 million in Q2 2022 and bottomed at -$60.6 million in Q4 2023.
  • Average Change in Inventory over 5 years is $9.8 million, with a median of $3.4 million recorded in 2021.
  • The sharpest move saw Change in Inventory plummeted 731.22% in 2021, then surged 40008.75% in 2022.
  • Year by year, Change in Inventory stood at -$4.3 million in 2021, then skyrocketed by 1244.13% to $49.3 million in 2022, then plummeted by 223.0% to -$60.6 million in 2023, then soared by 87.76% to -$7.4 million in 2024, then tumbled by 34.37% to -$10.0 million in 2025.
  • Business Quant data shows Change in Inventory for ICUI at -$10.0 million in Q4 2025, $7.0 million in Q3 2025, and $21.0 million in Q2 2025.